Preclinical evaluation of combretastatin A4 phosphate: A drug which selectively damages tumor neovasculature

被引：0
|
作者：
Chaplin, DJ
Hill, SA
Pettit, GR
机构：
[1] Mt Vernon Hosp, Canc Res Trust, Gray Lab, Tumor Microcirculat Grp, Northwood HA6 2JR, Middx, England
[2] Arizona State Univ, Dept Chem, Tempe, AZ 85287 USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
291
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [41] Tumor antivascular effects of radiotherapy combined with combretastatin A4 phosphate in human non-small-cell lung cancer
    Ng, Quan-Sing
    Goh, Vicky
    Carnell, Dawn
    Meer, Khalda
    Padhani, Anwar R.
    Saunders, Michele I.
    Hoskin, Peter J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1375 - 1380
  • [42] Combretastatin A4 phosphate (CA4P) targets vasculature in animal and human tumours
    Galbraith, SM
    Taylor, NJ
    Maxwell, RJ
    Lodge, M
    Tozer, GM
    Baddeley, H
    Wilson, I
    Prise, VE
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2000, 83 : 12 - 12
  • [43] Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4
    Ty, Nancy
    Pontikis, Renee
    Chabot, Guy G.
    Devillers, Emmanuelle
    Quentin, Lionel
    Bourg, Stephane
    Florent, Jean-Claude
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (05) : 1357 - 1366
  • [44] New antitubulin derivatives in the combretastatin A4 series:: synthesis and biological evaluation
    Borrel, C
    Thoret, S
    Cachet, X
    Guénard, D
    Tillequin, F
    Koch, M
    Michel, S
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (11) : 3853 - 3864
  • [45] Targeted Polymeric Micelle System for Delivery of Combretastatin A4 to Tumor Vasculature In Vitro
    Wang, Yiguang
    Yang, Tingyuan
    Wang, Xun
    Wang, Jiancheng
    Zhang, Xuan
    Zhang, Qiang
    PHARMACEUTICAL RESEARCH, 2010, 27 (09) : 1861 - 1868
  • [46] Phase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic results
    Rustin, GJS
    Galbraith, SM
    Anderson, H
    Stratford, M
    Folkes, LK
    Sena, L
    Gumbrell, L
    Price, PM
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2815 - 2822
  • [47] A phase I clinical trial assessing the safety and tolerability of combretastatin A4 phosphate injections
    Liu, Peng
    Qin, Yan
    Wu, Lingying
    Yang, Sheng
    Li, Nan
    Wang, Haijun
    Xu, Haiyan
    Sun, Kelin
    Zhang, Shuxiang
    Han, Xiaohong
    Sun, Yan
    Shi, Yuankai
    ANTI-CANCER DRUGS, 2014, 25 (04) : 462 - 471
  • [48] Targeted Polymeric Micelle System for Delivery of Combretastatin A4 to Tumor Vasculature In Vitro
    Yiguang Wang
    Tingyuan Yang
    Xun Wang
    Jiancheng Wang
    Xuan Zhang
    Qiang Zhang
    Pharmaceutical Research, 2010, 27 : 1861 - 1868
  • [49] In vivo monitoring of antivascular effects of combretastatin A4 phosphate in a breast cancer xenograft model
    Zhao, Dawen
    Richer, Edmond
    Liu, Li
    Ren, Ya
    Slavine, Nikolai
    Shay, Jerry W.
    Antich, Peter P.
    Mason, Ralph P.
    CANCER RESEARCH, 2006, 66 (08)
  • [50] Photoacoustic microscopy for evaluating combretastatin A4 phosphate induced vascular disruption in orthotopic glioma
    Bi, Renzhe
    Balasundaram, Ghayathri
    Jeon, Seungwan
    Tay, Hui Chien
    Pu, Yang
    Li, Xiuting
    Moothanchery, Mohesh
    Kim, Chulhong
    Olivo, Malini
    JOURNAL OF BIOPHOTONICS, 2018, 11 (10)
12345